Detalles de la búsqueda
1.
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
N Engl J Med
; 389(24): 2233-2244, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091530
2.
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
N Engl J Med
; 386(6): 509-520, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914868
3.
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.
Clin Infect Dis
; 77(11): 1521-1530, 2023 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466374
4.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Infection
; 51(5): 1273-1284, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648627
5.
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Clin Infect Dis
; 73(11): e4539-e4548, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32785589
6.
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.
Clin Infect Dis
; 70(9): 1799-1808, 2020 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400759
7.
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094127
8.
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.
Hepatology
; 67(6): 2113-2126, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473975
9.
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
J Antimicrob Chemother
; 72(9): 2616-2626, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575389
10.
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.
JAC Antimicrob Resist
; 5(2): dlad011, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880088
11.
Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis.
Open Forum Infect Dis
; 10(6): ofad225, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37383243
12.
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial.
Infect Dis Ther
; 12(12): 2725-2743, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995070
13.
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults.
NEJM Evid
; 1(2): EVIDoa2100043, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319179
14.
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.
Open Forum Infect Dis
; 7(3): ofaa054, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154325
15.
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial.
Infect Dis Ther
; 13(5): 1159-1160, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38662333
16.
Size and Shape Analysis of Error-Prone Shape Data.
J Am Stat Assoc
; 110(509): 368-379, 2015 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109745
Resultados
1 -
16
de 16
1
Próxima >
>>